Treatment 's considered Holy Grail of Oncology
" Unfortunately, the vast majority of pancreatic and colorectal cancers are resistant to currently available immunotherapies. Because of this, developing effective immunotherapeutic strategies directed against immunologically cold malignancies, like pancreatic and colorectal cancer, is a widely considered one of the holy grails of modern oncology, said Cleary" ------------------------------------------ https://www.google.com/amp/s/www.forbes.com/sites/victoriaforster/2021/04/24/scientists-predict-rise-in-deaths-from-pancreatic-cancer-and-young-onset-colorectal-cancer/amp/